An interventional study of Qigong Balance and Otago Balance in Diabetic Neuropathies, sponsored by Riphah International University. Not yet recruiting at 1 site in Pakistan. Open to participants aged 45 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-05-08.
Sponsored by Riphah International University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 24 studies in Diabetic Neuropathies by Riphah International University — 7 open to participants now, 7 under way, none of them phase 3. Diabetic Neuropathies · Riphah International University.
Among the 24 studies in Diabetic Neuropathies by Riphah International University, this one is the 12th largest by planned enrollment, is one of 4 that started in 2026, is one of 24 with no phase, and was the 21st registered.
539 studies on the registry are indexed under Diabetic Neuropathies; 80 are open to participants now.
Browse Diabetic Neuropathies studies →7 of the 24 studies in Diabetic Neuropathies by Riphah International University are open now, in 1 country. Recruiting first, the newest first:
Riphah International University · Sites in Pakistan
Ages 40 mo–75 mo
Riphah International University · Sites in Pakistan
Ages 45–67
Riphah International University · Sites in Pakistan
Ages 40–65
Riphah International University
Ages 18+
Riphah International University · Sites in Pakistan
Ages 18+
By country, each count listing its studies:
Of the 52 Diabetic Neuropathies studies recruiting now, 21 (40%) set no upper age limit and 24 (46%) stop at 75 or younger; 6 take children under 18; 3 take healthy volunteers.
This study: 45 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
24 studies; the count open now beside each. This study's row is marked.
First in 2020; this study’s year is marked. 4 started in 2026.
This study's planned enrollment of 44 is below the median of 68 across 449 interventional studies indexed under Diabetic Neuropathies.
Median enrollment 44 across the 24 interventional studies. Of the 16 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Riphah International University is the lead sponsor of 2,201 studies on the registry; 647 are open to participants now.
3 of the studies in Diabetic Neuropathies by Riphah International University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07619755Riphah International UniversitytSCS and AR Training on QoL and Physical Activity in Diabetic Neuropathy Patients | 2026-12-31 |
| NCT07619794Riphah International UniversitytSCS and AR on Pain and Balance in Diabetic Peripheral Neuropathy | 2026-12-31 |
| NCT07675720Riphah International UniversityConcurrent Training vs Soleus Push-Ups on Neurogenesis-Related Biomarkers in Diabetic Neuropathy Patients | 2027-09 |
Add all 3 to your calendar (.ics) → With an account.
Among the 24 studies in Diabetic Neuropathies by Riphah International University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study seeks to compare these two interventions to better understand their impact on key health outcomes in patients affected by diabetic neuropathy, providing valuable insights for clinicians and healthcare providers managing this challenging condition
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Qigong Balance
Other: Otago Balance
Quigong Balance Exercises 3 times per week for 60 minutes per session Open the Flow: Focus on fluid arm movements to enhance relaxation and improve circulation. Shaking Exercise: A full-body shake to release tension and promote energy flow. Lifting the Ball: Alternating arm movements simulating lifting a ball to improve upper body strength and coordination. Playing with Water: Slow, flowing movements that enhance balance and mindfulness. Weight Shifting and Balance Exercises: Stand with feet hip-width apart, shifting weight slowly from one leg to the other, holding each position for 10-15 seconds to engage stabilizing muscles in the legs and improve proprioception. Leg Lifts and Extensions: Perform controlled leg lifts (front, side, and back) to strengthen the quadriceps, hamstrings, and hip abductors.
Otago (Strengthening) Balance: Sit-to-stand exercises: to improve leg strength. Heel raises: to enhance calf strength. Toe stands: for improving foot stability. Balance Training: Single-leg stands: to enhance balance. Tandem walking: along a straight line. Side leg raises: to strengthen hip muscles 3 times per week for 60 minutes per session
Agility T-Test
The Agility T-Test is a performance-based assessment that measures an individual's agility and ability to change direction quickly. It involves a sequence where the participant runs to a designated point, makes sharp turns around markers in a T-shaped layout, and returns to the starting position.
Time frame: 12th week
Berg Balance Scale
is the gold standard test for static and dynamic balance abilities. The BBS is used to measure ability to maintain balance while doing functional task search as reach, standing position and transferences. It is a valid instrument used for the evaluation of effectiveness of interventions with quantitative description of function in clinical practice as well as research. It consists of 14 items including simple balance tasks from everyday life.
Time frame: 12th week
Functional Reach Test
FRT is a single item test for dynamic balance and acts as a quick screen for balance problems in older adults. The distance between the lengths of an outstretched arm in a maximal forward reach, while maintaining a fixed base of support is measured. A score of 6 inches or less indicates a significant increased risk for falls. A score between 6-10 inches indicates a moderate risk for falls. the Functional Reach Test (FRT) demonstrates an ICC of approximately 0.85 to 0.94
Time frame: 12th week
Gait Speed Test
The Gait Speed Test measures the time it takes for an individual to walk a specific distance, usually 10 meters, at their usual pace. It has demonstrated strong validity and reliability, with an Intra class Correlation Coefficient (ICC) often exceeding 0.90
Time frame: 12th week
10-Meter Walk Test
The 10-Meter Walk Test involves timing a participant as they walk a distance of 10 meters at their comfortable pace. It assesses gait speed, which is an important indicator of mobility and overall functional ability.
Time frame: 12th week
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for May 2026; primary completion for Aug 2026, 3 months later.
Of 138 non-industry interventional studies with no phase under Diabetic Neuropathies, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 24. This study's planned 3 months is below that.
Counting every sponsor, half of 153 studies reached it within 11 months; a quarter within 6 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Riphah International University →